(Q44579451)

4 December 2017

title

The risk of cervical cancer associated with specific types of human papillomavirus: a case-control study in a UK population (English)

1 reference

4 December 2017

main subject

cervix uterine cancer

1 reference

Ned G Powell

1

1 reference

4 December 2017

Sam J Hibbitts

2

1 reference

4 December 2017

Adam M Boyde

3

1 reference

4 December 2017

Robert G Newcombe

4

1 reference

4 December 2017

Amanda J Tristram

5

1 reference

4 December 2017

Alison N Fiander

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

25 May 2010

1 reference

International Journal of Cancer

4 December 2017

published in

1 reference

4 December 2017

volume

128

1 reference

4 December 2017

issue

7

1 reference

4 December 2017

page(s)

1676-1682

1 reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

4 December 2017

cites work

1 reference

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

21 January 2018

1 reference

The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers

21 January 2018

1 reference

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study

21 January 2018

1 reference

The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when?

21 January 2018

1 reference

Human papillomavirus infection: an anonymous prevalence study in South Wales, UK.

21 January 2018

1 reference

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

21 January 2018

1 reference

Cervical screening and health inequality in England in the 1990s

21 January 2018

1 reference

Sociodemographic and attitudinal correlates of cervical screening uptake in a national sample of women in Britain.

21 January 2018

1 reference

The carcinogenicity of human papillomavirus types reflects viral evolution.

21 January 2018

1 reference

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

21 January 2018

1 reference

Screening and adenocarcinoma of the cervix.

21 January 2018

1 reference

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States

21 January 2018

1 reference

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

21 January 2018

1 reference

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

21 January 2018

1 reference

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

21 January 2018

1 reference

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25485

1 reference

4 December 2017

1 reference